🔴 MannKind is trading 5% down today as biotech and broader risk-off pressures weigh

MannKind is trading 5.39% lower at $3.51 on October 7, with biotech and broader risk-off pressure weighing on shares.

• MannKind closed down 2.88% on October 6; no fresh company-specific announcement surfaced in the search.
• The biotech ETF XBI is down 2.50%.
• Higher Treasury yields, Brent crude above $101, and Strait of Hormuz tensions weighed on global equities ahead of the Fed minutes.